Related content

Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial

By Richens A.   Chadwick D.W.   Duncan J.S.   Dam M.   Gram L.   Mikkelsen M.   Morrow J.   Mengel H.   Shu V.   McKelvy J.F.   Pierce M.W.  

Epilepsy Research, Vol. 21, Iss. 1, 1995-05 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Stress and avoidance in Pseudoseizures: testing the assumptions

By Frances P.L.   Baker G.A.   Appleton P.L.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 241-249

Elsevier

Access to resources Recommend Favorite

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

By Pietka E.   H. K.H.   Ben-Menachem E.   Soderfelt B.   Hamberger A.   Hedner T.   Persson L.I.  

Epilepsy Research, Vol. 21, Iss. 3, 1995-07 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

The diagnosis of pseudoseizures in epileptic and non-epileptic patients

By Martins A.   Lemos M.S.   Paiva T.  

Electroencephalography and Clinical Neurophysiology, Vol. 99, Iss. 4, 1996-10 ,pp. : 319-320

Elsevier

Access to resources Recommend Favorite